EV344/#770 Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial
Year: 2024
Type: article
Study design: Clinical Trial
Authors: Shuang Ye, Yi Fu, Shuai Liu, Jun Wang, Lin Zhou, Wei Jiang, Xuan Pei, Wenbin Shen, Min Sun, Boer Shan, Huijuan Yang
Institution: Fudan University Shanghai Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403533910
